Keep REMS Requirements Straight
May 2018
Drugs with Risk Evaluation and Mitigation Strategies (REMS) are back in the spotlight...due to updates to some of these med safety programs.
The iPLEDGE program for isotretinoin will now allow pharmacies to get a Risk Management Authorization (RMA) through their pharmacy network without having to call or go to the iPLEDGE website.
Plus short-acting opioids will soon have REMS, with FDA considering mandatory pain management training for healthcare providers.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote